Advertisement

Topics

FDA-approved 'safe' daily BPA exposure may contribute to insulin resistance

21:41 EDT 16 Sep 2018 | News-Medical.net

In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release.

Original Article: FDA-approved 'safe' daily BPA exposure may contribute to insulin resistance

NEXT ARTICLE

More From BioPortfolio on "FDA-approved 'safe' daily BPA exposure may contribute to insulin resistance"

Advertisement
Quick Search
Advertisement
Advertisement